GATE-102

N/A

Report date: 2022/10/12 16:37:48
NME

Base Information

Drug NameGATE-102
Drug Alias NameGATE-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 2 antagonistsMetabotropic glutamate receptor 3 antagonists
TargetsMetabotropic glutamate receptor 2Metabotropic glutamate receptor 3
Therapy Area/IndicationsIdiopathic Hypersomnia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGate Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGate Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Hypersomnia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A